NEI
PTCT icon

Northwest & Ethical Investments’s PTC Therapeutics PTCT Stock Holding History

Northwest & Ethical Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,800
Closed -$193K – 566
2026
Q1 		$193K Buy
+2,800
New +$198K ﹤0.01% 487

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Northwest & Ethical Investments's PTCT Position: Q2 2026 in Review

Northwest & Ethical Investments sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 2,800 shares — an estimated $193K sold.

Northwest & Ethical Investments first reported a position in PTCT in Q1 2026 and held it in 1 quarter. The position peaked at $193K in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Northwest & Ethical Investments reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northwest & Ethical Investments sold 2,800 PTC Therapeutics shares in Q2 2026, an estimated $193K.
  • Northwest & Ethical Investments first reported a position in PTC Therapeutics in Q1 2026 and held it in 1 quarter.
  • Northwest & Ethical Investments's PTC Therapeutics position peaked at $193K in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.